Picture of Ambu A/S logo

AMBU B Ambu A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Brief: Ambu Q1 Adjusted EBIT Falls To DKK 40 Million

Feb 8 (Reuters) - Ambu A/S  AMBUb.CO :
    * REG-AMBU A/S: INTERIM REPORT FOR Q1 2021/22
    * REG-AMBU A/S: INTERIM REPORT FOR Q1 2021/22
    * Q1 REVENUE DKK 1,031 MILLION VERSUS DKK 1,013 MILLION YEAR
AGO
    * Q1 EBIT EX. ITEMS DKK 40 MILLION VERSUS DKK 148 MILLION
YEAR AGO
    * OUTLOOK FOR 2021/22 FINANCIAL YEAR IS REVISED DUE TO
UNCERTAINTIES REGARDING CONTINUED IMPACT OF OMICRON
    * OUTLOOK FY 2021/22: OUTLOOK FOR ORGANIC GROWTH IS REVISED
FROM
"15-19%" TO "15%+" (15 PERCENT OR HIGHER)
    * OUTLOOK FY 2021/22: EBIT MARGIN IS REVISED FROM "7-9%" TO
"7%+"
(7 PERCENT OR HIGHER)
    * OUTLOOK FY 2021/22: ORGANIC GROWTH OF 15%+
    * OUTLOOK FY 2021/22:
    * Q1 SALES OF ENDOSCOPES AT 419,000 UNITS VERSUS  370,000
UNITS
YEAR AGO

Source text for Eikon:  ID:nGNE4KbbSv 
Further company coverage:  AMBUb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Ambu A/S

See all news